Received for publication February 4, 2005.
Revised February 25, 2005.
Accepted for publication February 28, 2005.

Place Conditioning and Locomotor Effects of N-Substituted, 4',4"-Difluorobenztropine Analogues in Rats

Abstract

Previous studies demonstrated that analogues of benztropine (3-(diphenyl-methoxy)tropane; BZT) bind to the dopamine (DA) transporter with high affinity, inhibit DA uptake, but do not maintain rates of responding in self-administration procedures comparable to those maintained by cocaine. Some BZT analogues have an onset of action that is slower than that for cocaine which may contribute to this decreased effectiveness. In addition, some BZT analogues have affinity for muscarinic-M1 receptors which may interfere with reinforcing effects. The present study assessed effects of BZT analogues in place-conditioning procedures designed to accommodate variations in onset of effect. BZT analogues with variations in relative affinities for the DA transporter over M1 receptors from equal (AHN 1-055) to 16-fold (JHW 007) were compared to cocaine and the muscarinic antagonist, atropine. Cocaine (10-20 mg/kg) but not atropine (1.0-5.6 mg/kg) produced dose-related place conditioning. The N-methyl-substituted BZT analogue, AHN 1-055, was without significant effects at doses that ranged from 0.3-3.0 mg/kg, and when administered up to 90 min before conditioning trials. In contrast, effects of AHN 2-005 (0.1-10.0 mg/kg) were significant and those of JHW 007 approached significance when administered 45 min, but not immediately or 90 min before trials. Atropine blocked the effect of AHN 2-005 and approached significant antagonism of cocaine. The present study further supports and extends previous results showing minimal preclinical indications of abuse liability of BZT analogues, and suggests that these differences from cocaine are not entirely accounted for by a slower onset of action or muscarinic M1 receptor affinity.

Key words: AHN 1-055, AHN 2-005, JHW 007, benztropine analogues, cocaine, place conditioning

This article has been cited by other articles:

				G. Tanda, A. L. Ebbs, T. A. Kopajtic, L. M. Elias, B. L. Campbell, A. H. Newman, and J. L. Katz Effects of Muscarinic M1 Receptor Blockade on Cocaine-Induced Elevations of Brain Dopamine Levels and Locomotor Behavior in Rats J. Pharmacol. Exp. Ther., April 1, 2007; 321(1): 334 - 344. [Abstract] [Full Text] [PDF]

				A. A. Othman, S. A. Syed, A. H. Newman, and N. D. Eddington Transport, Metabolism, and in Vivo Population Pharmacokinetics of the Chloro Benztropine Analogs, a Class of Compounds Extensively Evaluated in Animal Models of Drug Abuse J. Pharmacol. Exp. Ther., January 1, 2007; 320(1): 344 - 353. [Abstract] [Full Text] [PDF]